Empagliflozin for the treatment of nonalcoholic steatohepatitis in patients with type 2 diabetes mellitus - Lai, L L; Vethakkan, S R; Nik Mustapha, N R; Mahadeva, S; Chan, W K (Dig Dis Sci, 2020)